Effect of aspirin treatment on abacavir-associated platelet hyperreactivity in HIV-infected patients

Aspirin reduces ABC-induced in vivo platelet activation and platelet hyperreactivity in HIV-infected patients, however without normalizing them. Whether the observed reduction of platelet activation is sufficient to prevent cardiovascular events requires a prospective trial.